Celldex Therapeutics
CLDX
#4701
Rank
โ‚ฌ1.68 B
Marketcap
25,29ย โ‚ฌ
Share price
-0.51%
Change (1 day)
2.72%
Change (1 year)

Celldex Therapeutics (CLDX) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚ฌ0.51 Billion

According to Celldex Therapeutics's latest financial reports the company has โ‚ฌ0.51 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Celldex Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ0.71 B84.9%
2023-12-31$โ‚ฌ0.38 B27.66%
2022-12-31$โ‚ฌ0.30 B-17.9%
2021-12-31$โ‚ฌ0.37 B117.61%
2020-12-31$โ‚ฌ0.17 B102.79%
2019-12-31$โ‚ฌ83.93 M-22.6%
2018-12-31$โ‚ฌ0.10 B-44.95%
2017-12-31$โ‚ฌ0.19 B-21.93%
2016-12-31$โ‚ฌ0.25 B-4.89%
2015-12-31$โ‚ฌ0.26 B52.46%
2014-12-31$โ‚ฌ0.17 B-24.85%
2013-12-31$โ‚ฌ0.23 B219.83%
2012-12-31$โ‚ฌ72.4 M36.82%
2011-12-31$โ‚ฌ52.91 M-6.47%
2010-12-31$โ‚ฌ56.57 M9.88%
2009-12-31$โ‚ฌ51.48 M296.93%
2008-12-31$โ‚ฌ12.97 M-1773.27%
2007-12-31$-โ‚ฌ0.78 Million-147.33%
2006-12-31$โ‚ฌ1.63 M-90.71%
2005-12-31$โ‚ฌ17.63 M-37.72%
2004-12-31$โ‚ฌ28.31 M27.68%
2003-12-31$โ‚ฌ22.17 M-26.04%
2002-12-31$โ‚ฌ29.98 M-41.5%
2001-12-31$โ‚ฌ51.25 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Seagen
SGEN
โ‚ฌ2.19 B 326.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-โ‚ฌ0.25 Billion-146.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.50 B-2.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.25 B 1,507.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ79.94 B 15,458.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ18.18 B 3,438.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
โ‚ฌ2.39 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA